Biodesix (BDSX) Notes Payables: 2019-2025
Historic Notes Payables for Biodesix (BDSX) over the last 5 years, with Sep 2025 value amounting to $11,000.
- Biodesix's Notes Payables fell 62.07% to $11,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $11,000, marking a year-over-year decrease of 62.07%. This contributed to the annual value of $21,000 for FY2024, which is 58.82% down from last year.
- As of Q3 2025, Biodesix's Notes Payables stood at $11,000, which was down 31.25% from $16,000 recorded in Q2 2025.
- Over the past 5 years, Biodesix's Notes Payables peaked at $14.3 million during Q3 2022, and registered a low of $11,000 during Q3 2025.
- Over the past 3 years, Biodesix's median Notes Payables value was $37,000 (recorded in 2024), while the average stood at $34,364.
- As far as peak fluctuations go, Biodesix's Notes Payables plummeted by 99.92% in 2021, and later skyrocketed by 71,570.00% in 2022.
- Quarterly analysis of 5 years shows Biodesix's Notes Payables stood at $19,000 in 2021, then spiked by 157.89% to $49,000 in 2022, then grew by 4.08% to $51,000 in 2023, then slumped by 58.82% to $21,000 in 2024, then tumbled by 62.07% to $11,000 in 2025.
- Its Notes Payables stands at $11,000 for Q3 2025, versus $16,000 for Q2 2025 and $18,000 for Q1 2025.